Search

You searched for "interview"

1660 results found

Optic nerve swelling – your survival guide (part 1)

1 August 2017 | | EYE - Neuro-ophthalmology
Assessment of optic nerve appearance and functions is a daily routine in neuro-ophthalmology. Following a recent high profile court case there has been a significant increase in the amount of referral to ophthalmology departments to assess the optic nerve and...

An introduction to research governance

1 February 2014 |
Research is the process of acquiring new generalisable knowledge and should be fully integrated into health care work. There is a growing drive to encourage and further develop evidence-based practice in ophthalmology so that staff and patients benefit from improved...

Vitreomacular traction: natural course vs. vitrectomy vs. ocriplasmin

3 June 2024 | | EYE - Vitreo-Retinal
Over time, the vitreous gel completely separates from the retina in a process known as a posterior vitreous detachment (PVD). In some instances, however, the vitreous does not detach entirely and remains adherent to the macula. The term vitreomacular traction...

Expensive Malware

1 February 2014 |
Cryptolocker and similar ransomware There is a new breed of computer malware that is spreading rapidly. The first major manifestation of this new type is known as Cryptolocker. At present it’s a Windows only problem (all versions), but it’s likely...

Paediatric ptosis

1 December 2018 | | EYE - Paediatrics, EYE - General
Manoj Parulekar and colleagues provide a comprehensive overview of the diagnosis, assessment and management of childhood ptosis. Blepharoptosis (commonly referred to as ptosis – Greek, πτῶσις, ‘to fall’) is a condition where the upper eyelid is in an abnormally low...

Discussing treatment modalities for bilateral wet AMD

1 December 2014 | | EYE - Vitreo-Retinal
A 65-year-old lady with bilateral wet AMD and vision of 6/24 comes with an internet search about current therapies. How do you explain the various treatment modalities available? There are two NICE approved treatments for wet age-related macular degeneration (AMD)....

Assessing everyday visual function in dry AMD – what matters to the person?

1 April 2019 | | EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is the primary cause of blindness in the developed world and is accountable for more than one half of sight impairment registrations within England and Wales [1]. AMD is prevalent in people aged 60 years and...

Real world data of post-IVT endophthalmitis, from a nurse-delivered intravitreal injection service

3 April 2023 | | EYE - General
Introduction Intravitreal injection of neutralising anti-vascular endothelial growth factor (VEGF) antibody was licenced more than a decade ago, and over the years there has been proportionate increase in the number of intravitreal injections [1]. Injection of a therapeutic agent through...

90% of NHS trusts now have electronic patient records

22 November 2023 | EPR, Digitalisation, NHS, Electronic patient records
The NHS has met the government’s target for 90% of trusts adopting electronic patient records (EPR) in hospitals ahead of schedule.

Scottish Braille Press makes accessibility statement with new 60k braille printer investment

14 February 2025 | charity, RNIB, Louis Braille, Sight Scotland
The Scottish Braille Press, which is part of Sight Scotland, has announced a significant investment in a state-of-the-art braille printer to bolster its support for individuals with vision impairments across the UK. This new printer, imported from Norway at a...

Real-world experience and outcomes of SLT laser used as a first-line treatment in ocular hypertension patients in a United Kingdom National Health Service setting

3 October 2022 |
The management of raised intraocular pressure (IOP) in the context of ocular hypertension (OHT) and primary open angle glaucoma (POAG) remains a major contributor to the workload of ophthalmology units across the UK. Treatment of these conditions has historically centred...

PACK-crosslinking for infectious keratitis

1 October 2015 | | EYE - Cornea
Corneal cross-linking with riboflavin and UV-A light (CXL) is a technology that has been initially developed to treat corneal ectatic disorders [1]. Its effect in stabilising diseases such as keratoconus was reported in numerous trials with excellent long-term outcomes and...